Daily plasma exchange involves removing a predetermined quantity of plasma/kg body weight and replacing it with an equal volume of new frozen plasma. It supplies ADAMTS13 and eliminates autoantibodies associated with TTP. Cryoprecipitates and fresh frozen plasma may also be employed [47,48]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.